MedTrace Logo

Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia

NCT04599998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2024-05-16

No results posted yet for this study

Summary

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus (SARS-CoV-2) that can progress to severe multiorgan disease requiring hospitalization. The medium and long-term impact in survivors of COVID-19 on lung function, imaging by thoracic CT, exercise capacity, and health-related quality of life and the relation of these parameters remains to be determined.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

spirometry, thoracic CT, CPET, 6 minute walking test, SF-36 questionnaire

Participants will perform spirometry, lung diffusion capacity of carbon monoxide, 6-minute walk test (6MWT), Short form-36 (SF-36) questionnaire and cardiopulmonary exercise testing (CPET) after 6-12 months (Visit 1) of COVID-19. Clinical, laboratory and chest image data during the COVID-19 hospitalization will be obtained from medical records.

Sponsors & Collaborators

  • Koc University Hospital

    lead OTHER

Principal Investigators

  • Benan Çağlayan, Prof Dr · Koç University Hospital Pulmonology Department

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2022-02-15
Completion
2023-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04599998 on ClinicalTrials.gov